Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In the health screening solutions business, the Company is pursuing higher value-added services and the use of AI and business process re-engineering. In the health management cloud business, it established a dedicated sales organization and acquired new customers. Going forward, it will pursue market development, price revisions, the launch of new plans and the use of AI.
No applicable items regarding the going concern assumption
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥14,778 million |
| Operating profit | ¥1,186 million |
| Ordinary income | ¥1,164 million |
| Profit attributable to owners of the parent | ¥822 million |
| Net income per share | ¥68.13 |
| Operating Margin | 8.0% |
| Equity ratio | End of the current fiscal period 59.9% / End of previous period Not disclosed |
| Total assets | ¥9,729 million |
| Net assets | ¥5,832 million |
| Cash flows from operating activities | ¥1,099 million |
| Cash flows from investing activities | ¥-111 million |
| Cash flows from financing activities | ¥1,485 million |
| Cash and cash equivalents at end of period | ¥5,260 million |
| Full-year earnings forecast | Net Sales ¥17,500 million (YoY +18.4%) / Operating profit ¥1,600 million (YoY +34.9%) / Ordinary income ¥1,555 million (YoY +33.6%) / Net income ¥1,150 million (YoY +40.0%) |
| Annual Dividend Forecast | ¥34.4 → ¥40（+16.3%） |
| Payout ratio | 43.3% |
| Segment revenue | Health Checkup Solutions Business ¥13,018.49 thousand / Health Management Cloud Business ¥1,523.76 thousand / Medical institution support business ¥236.1 thousand |
| Segment profit | Health Checkup Solutions Business ¥379.08 thousand / Health Management Cloud Business ¥767.33 thousand / Medical institution support business ¥39.82 thousand |
| Depreciation and amortization | ¥281,631 thousand |
| Disclosure regarding the going concern assumption | No applicable items regarding the going concern assumption |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社あしたのチーム / Excluded Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (institutional investors, securities analysts and individual investors) |
| Issued Shares at Period-End | 12,463,400 Shares |
| Factors Behind Changes in Business Performance | In the health screening solutions business, the Company is pursuing higher value-added services and the use of AI and business process re-engineering. In the health management cloud business, it established a dedicated sales organization and acquired new customers. Going forward, it will pursue market development, price revisions, the launch of new plans and the use of AI. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This reflects deeper and broader penetration of the enterprise market, accelerated development of the mid-sized and small business market, higher average customer spending through price revisions and the launch of new plans for Growbase, enhanced functionality through AI implementation and utilization, and non-continuous growth investments.